GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$243.25−1.63 (-0.67%)
Close on Nov 17, 2026Market cap $14.40BP/E –Yield –
Glaukos pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Glaukos's pe ratio was 163.2× on Jul 29, 2022, against 824.4× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 163.2× | +64.0 |
| 2020 | Apr 30, 2020 | 99.2× | −266.1 |
| 2017 | Jul 31, 2017 | 365.3× | −320.7 |
| 2016 | Dec 30, 2016 | 686.0× | – |
See a number that looks wrong?